🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

NeueHealth executive sells shares worth over $4,000

Published 03/20/2024, 08:14 PM
© Reuters.
NEUE
-

NeueHealth, Inc. (NYSE:NEUE) announced that Jeffrey J. Scherman, the company's Chief Accounting Officer, has sold 568 shares of common stock at an average price of $7.27 per share, totaling approximately $4,129. The transactions occurred on March 18, 2024, and were disclosed in a recent filing with the Securities and Exchange Commission.

The sale was executed in multiple transactions with prices ranging from $7.16 to $7.39 per share. It's noteworthy that these shares were sold by Scherman to satisfy tax withholding obligations related to the vesting of restricted stock units. This indicates that the sale was not a discretionary transaction by the reporting person.

Following the sale, Scherman retains ownership of 3,440 shares of NeueHealth, Inc. The company, formerly known as Bright Health Group Inc (NYSE:NEUE)., operates within the hospital and medical service plans industry and is incorporated in Delaware.

Investors and stakeholders often monitor insider transactions as they can provide insights into an executive's view of the company's stock value and financial health. The recent transaction by Scherman is a routine sale related to tax obligations, which is a common practice among corporate executives.

NeueHealth, Inc. has not made any further comments regarding the transaction. Interested parties, including shareholders and the SEC, can request detailed information about the individual prices at which the shares were sold within the reported range.

InvestingPro Insights

As NeueHealth, Inc. (NYSE:NEUE) navigates through a challenging period, the recent insider transaction may draw attention to the company's financial health and future prospects. According to InvestingPro data, the company's market capitalization stands at a modest $55.99 million, reflecting a smaller player within the industry. Investors should note that the company's revenue has experienced a significant decline over the last twelve months, with a decrease of approximately 51.87%. This aligns with the InvestingPro Tip that analysts anticipate a sales decline in the current year, which could be a point of concern for potential investors.

Moreover, the stock has demonstrated high price volatility, as indicated by the 34.65% return over the last three months, coupled with a notable 17.87% decrease in the past month. The price volatility is further underscored by the company's P/E Ratio (Adjusted) for the last twelve months as of Q4 2023, which is listed at -0.14, suggesting that the market has concerns about profitability. This is consistent with another InvestingPro Tip highlighting that the company is not expected to be profitable this year.

For those considering an investment in NeueHealth, Inc., it's worth exploring the comprehensive list of InvestingPro Tips available on InvestingPro. There are additional insights that could further inform investment decisions. Interested readers can take advantage of a special offer by using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With this offer, investors can access a total of 11 InvestingPro Tips for NeueHealth, Inc., providing a deeper understanding of the company's financial position and market performance.

The next earnings date is set for May 3, 2024, which may offer further clarity on the company's trajectory and whether the current trends will persist. Until then, investors may wish to closely monitor the company's performance metrics and insider transactions for additional insights into the company's direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.